Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
38.60
+0.99 (2.63%)
At close: Sep 4, 2026, 4:00 PM EDT
38.12
-0.48 (-1.24%)
After-hours: Sep 4, 2026, 7:30 PM EDT
Neurogene Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 112.49 | 103.85 | 136.59 | 148.21 | 82.02 | 70.54 |
Short-Term Investments | 112.91 | 165.17 | 175.82 | 48.95 | - | - |
Cash & Short-Term Investments | 225.39 | 269.01 | 312.41 | 197.16 | 82.02 | 70.54 |
Cash Growth | -17.90% | -13.89% | 58.45% | 140.37% | 16.27% | - |
Other Receivables | 0.43 | 0.46 | 0.65 | 0.6 | 0.99 | 0.79 |
Receivables | 0.43 | 0.46 | 0.65 | 0.6 | 0.99 | 0.79 |
Prepaid Expenses | 2.56 | 1.94 | 1.89 | 1.5 | 1.08 | 1.91 |
Other Current Assets | 0.53 | 0.36 | 0.98 | 1.1 | 0.63 | 0.71 |
Total Current Assets | 228.91 | 271.77 | 315.92 | 200.35 | 84.72 | 73.96 |
Property, Plant & Equipment | 14.01 | 15.46 | 18.49 | 20.95 | 24.55 | 27.53 |
Other Long-Term Assets | 1.45 | 1.37 | 1.31 | 1.27 | - | - |
Total Assets | 244.36 | 288.6 | 335.73 | 222.57 | 109.27 | 101.49 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 3.29 | 1.95 | 1.34 | 2.6 | 0.63 | 5.63 |
Accrued Expenses | 14.11 | 10.19 | 9.39 | 16.76 | 5.16 | 4.35 |
Current Portion of Leases | 3.03 | 3.06 | 3 | 2.6 | 0.7 | 0.61 |
Other Current Liabilities | 1.08 | 1.2 | 1.43 | 1.02 | 0.17 | 0.27 |
Total Current Liabilities | 21.51 | 16.41 | 15.16 | 22.97 | 6.65 | 10.86 |
Long-Term Leases | 5.32 | 6.83 | 9.43 | 12.37 | 3.99 | 4.6 |
Other Long-Term Liabilities | 0.41 | 0.48 | 0.77 | 1.21 | - | - |
Total Liabilities | 27.23 | 23.72 | 25.36 | 36.55 | 10.64 | 15.46 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | - | - | - | - | - | 0 |
Additional Paid-In Capital | 635.2 | 617.54 | 572.67 | 373.18 | 5.1 | 3.77 |
Retained Earnings | -418.07 | -352.65 | -262.3 | -187.15 | -150.84 | -95.65 |
Total Common Equity | 217.13 | 264.89 | 310.38 | 186.02 | -145.74 | -91.88 |
Shareholders' Equity | 217.13 | 264.89 | 310.38 | 186.02 | 98.63 | 86.03 |
Total Liabilities & Equity | 244.36 | 288.6 | 335.73 | 222.57 | 109.27 | 101.49 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 8.35 | 9.89 | 12.43 | 14.97 | 4.69 | 5.21 |
Net Cash (Debt) | 217.05 | 259.12 | 299.98 | 182.19 | 77.33 | 65.34 |
Net Cash Growth | -17.65% | -13.62% | 64.65% | 135.59% | 18.36% | - |
Net Cash Per Share | 9.85 | 12.15 | 17.08 | 39.12 | 196.01 | 16.13 |
Filing Date Shares Outstanding | 20.01 | 15.57 | 14.93 | 12.85 | 5.67 | 4.05 |
Total Common Shares Outstanding | 15.83 | 15.49 | 14.85 | 12.82 | 5.67 | 4.05 |
Working Capital | 207.41 | 255.36 | 300.77 | 177.38 | 78.07 | 63.1 |
Book Value Per Share | 13.72 | 17.10 | 20.89 | 14.51 | -25.72 | -22.68 |
Tangible Book Value | 217.13 | 264.89 | 310.38 | 186.02 | -145.74 | -91.88 |
Tangible Book Value Per Share | 13.72 | 17.10 | 20.89 | 14.51 | -25.72 | -22.68 |
Machinery | 11.22 | 10.87 | 9.6 | 9.31 | 9.04 | 6.01 |
Construction In Progress | 0.28 | 0.32 | 1.31 | 0.23 | 0.25 | 2.86 |
Leasehold Improvements | 15.64 | 15.42 | 15.4 | 15.38 | 15.3 | 15.29 |